PX
62
2
EFX
54
5
CB
64
6
NKE
48
6
AAP
24
-3
AIG
74
5
DG
74
4
VFC
79
3
O
48
2
AIZ
59
5
GIS
57
3
ICE
67
4
MCO
61
5
NOC
51
3
AA
72
3
NI
62
2
WAT
50
-3
OMC
69
4
RL
79
3
CA
24
-3
PX
62
2
EFX
54
5
CB
64
6
NKE
48
6
AAP
24
-3
AIG
74
5
DG
74
4
VFC
79
3
O
48
2
AIZ
59
5
GIS
57
3
ICE
67
4
MCO
61
5
NOC
51
3
AA
72
3
NI
62
2
WAT
50
-3
OMC
69
4
RL
79
3
CA
24
-3
Financhill
Back

Logitech International SA Vs. Nektar Therapeutics Industry Stock Comparison

Buy
55

LOGI
Logitech International SA

Last Price:
$120.41
Seasonality Move:
4.82%
Sell
33

NKTR
Nektar Therapeutics

Last Price:
$51.10
Seasonality Move:
11.58%
Buy
55
Logitech International SA (LOGI) is a Buy

Is Logitech International SA a Buy, Sell or Hold?

  • The current Logitech International SA [LOGI] share price is $120.43. The Score for LOGI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • LOGI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LOGI Stock Price Chart

What is Logitech International SA's stock price today?

  • The Logitech International SA share price today is $120.43
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LOGI is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $51.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

LOGI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.55 Buy
Relative Strength Index (14 RSI): 61.01 Buy
Chaikin Money Flow: 25358 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.49 - 120.51) Buy
Bollinger Bands (100): (100.21 - 116.61) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: -893008 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.73 - 61.07) Sell
Bollinger Bands (100): (32.3 - 62.42) Buy

LOGI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 118.89 Buy
20-day SMA: 114.85 Buy
50-day SMA: 114.18 Buy
200-day SMA: 97.05 Buy
8-day EMA: 118.47 Buy
20-day EMA: 116.53 Buy
50-day EMA: 113.78 Buy
200-day EMA: 101.76 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.44 Sell
20-day SMA: 58.08 Sell
50-day SMA: 58.52 Sell
200-day SMA: 30.43 Buy
8-day EMA: 56.58 Sell
20-day EMA: 57.71 Sell
50-day EMA: 55.82 Sell
200-day EMA: 37.69 Buy

Logitech International SA Earnings Growth & LOGI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.86 per share, and an increase next year of $0.74 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Logitech International SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):